CBS EXPANDING ITS MEDICAL COMMUNCATIONS BUSINESS
Executive Summary
CBS EXPANDING ITS MEDICAL COMMUNCATIONS BUSINESS with the acquisition of TransMedica, a closely-held firm that produces medical symposia, monograph series, video-cassette series, films and audiovisual products. Much of TransMedica's medical communications is done through "MDTV," a natl. program service for MDs established in 1983, which is carried by many cable systems, by Chicago "superstation" WGN and by local UHF and VHF stations "in each of the top 50 Nielson markets," CBS said. The addition of TransMedica complements CBS' W. B. Saunders subsidiary, which publishes reference works for the medical, dental and veterinary professions, textbooks and related educational materials. The acquisition "broadens our strength in the growing market for medical information for health care professionals," CBS said. TransMedica will operate as a separate unit of CBS Educational and Professional Publishing, a division of CBS/Publishing Group. Its founders will continue to manage the firm: George Rohr will be president of the new unit and Anne Holmes will be Director of Operations.
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth